STOCK TITAN

Averin Capital Acquisition Corp. Announces the Pricing of $250,000,000 Initial Public Offering

(Neutral)
(Neutral)

Averin Capital Acquisition Corp (NASDAQ:ACAAU) priced a $250,000,000 initial public offering of 25,000,000 units at $10.00 per unit, expected to begin trading on Feb 19, 2026.

Each unit includes one Class A share and one-sixth of a warrant (whole warrant strike $11.50). $10.00 per unit will be deposited into a trust account. The offering is expected to close on Feb 20, 2026 and includes a 45-day option to sell an additional 3,750,000 units. The sponsor is a blank-check company targeting technology and health, led by David A. Berry and Alex Lau; Deutsche Bank is sole book-runner.

Loading...
Loading translation...

Positive

  • $250,000,000 raised via 25,000,000 units at $10.00
  • $10.00 per unit placed into a trust account at closing
  • Nasdaq listing expected Feb 19, 2026 under ticker ACAAU
  • Underwriter option for 3,750,000 additional units (15%)

Negative

  • No identified acquisition target at time of offering
  • Warrants exercisable at $11.50 could create future dilution
  • Closing subject to customary conditions; offering not guaranteed to close

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

New York, NY, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Averin Capital Acquisition Corp. (the “Company”) announced today the pricing of its initial public offering of 25,000,000 units at a price of $10.00 per unit. The units are expected to be listed on the Nasdaq Global Market (“Nasdaq”) and begin trading on February 19, 2026, under the ticker symbol “ACAAU.” Each unit consists of one Class A ordinary share and one-sixth of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. An amount equal to $10.00 per unit will be deposited into a trust account upon the closing of the offering. Once the securities constituting the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “ACAA” and “ACAAW,” respectively. The offering is expected to close on February 20, 2026 subject to customary closing conditions. The Company has granted the underwriters a 45-day option to purchase up to an additional 3,750,000 units at the initial public offering price to cover over-allotments, if any.

The Company is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company may pursue an acquisition opportunity in any business or industry but expects to focus on a target in technology and health industries.

The Company’s management team is led by David A. Berry, the Chairman and Chief Executive Officer, and Alex Lau, its Chief Financial Officer and Secretary. The Board of Directors also includes Ulrik Schulze, Graeme Bell, and Mary T. Szela.

Deutsche Bank Securities Inc. is acting as sole book-running manager for the offering.

The offering is being made only by means of a prospectus. When available, copies of the prospectus may be obtained from Deutsche Bank Securities Inc., Attention: Capital Markets, 1 Columbus Circle, New York, New York 10019, or by email at prospectus.cpdg@db.com or by accessing the SEC’s website, www.sec.gov.

A registration statement relating to the securities has been filed with the U.S. Securities and Exchange Commission (“SEC”) and became effective on February 18, 2026. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Forward-Looking Statements

This press release contains statements that constitute “forward-looking statements,” including with respect to the expected closing of the proposed initial public offering and search for an initial business combination. No assurance can be given that the offering discussed above will be completed on the terms described, or at all.

Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the “Risk Factors” section of the Company’s registration statement and prospectus for the Company’s initial public offering filed with the SEC. Copies of these documents are available on the SEC’s website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Investor Contacts

Averin Capital Acquisition Corp.
David Berry, Chief Executive Officer
david@averincapital.com


FAQ

When will Averin Capital Acquisition Corp (ACAAU) begin trading on Nasdaq?

ACAAU is expected to begin trading on Nasdaq on Feb 19, 2026. According to the company, the units will trade under ACAAU and, after separation, shares and warrants are expected to trade as ACAA and ACAAW.

How large is the Averin Capital Acquisition Corp (ACAAU) IPO and what is its structure?

The IPO is for 25,000,000 units priced at $10.00 each, totaling $250,000,000. According to the company, each unit contains one Class A ordinary share and one-sixth of a redeemable warrant.

What are the warrant terms in the Averin Capital Acquisition Corp (ACAAU) offering?

Each whole warrant permits purchase of one Class A share at $11.50, subject to adjustments. According to the company, units include one-sixth of a warrant and only whole warrants will trade after separation.

Does Averin Capital Acquisition Corp (ACAAU) have an over-allotment option in the IPO?

Yes. The company granted underwriters a 45-day option to buy up to 3,750,000 additional units at the IPO price. According to the company, this covers potential over-allotments if any.

What industries will Averin Capital Acquisition Corp (ACAAU) target for a business combination?

Averin Capital expects to focus on targets in technology and health industries. According to the company, it is a blank-check vehicle formed to effect a merger, acquisition, or similar business combination.